These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 15331654)
1. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum. Eyerman DJ; Yamamoto BK J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654 [TBL] [Abstract][Full Text] [Related]
2. Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system. Wilhelm CJ; Johnson RA; Lysko PG; Eshleman AJ; Janowsky A J Pharmacol Exp Ther; 2004 Sep; 310(3):1142-51. PubMed ID: 15102929 [TBL] [Abstract][Full Text] [Related]
6. Methamphetamine-induced spectrin proteolysis in the rat striatum. Staszewski RD; Yamamoto BK J Neurochem; 2006 Mar; 96(5):1267-76. PubMed ID: 16417574 [TBL] [Abstract][Full Text] [Related]
7. Relation between methamphetamine-induced monoamine depletions in the striatum and sequential motor learning. Daberkow DP; Kesner RP; Keefe KA Pharmacol Biochem Behav; 2005 May; 81(1):198-204. PubMed ID: 15894079 [TBL] [Abstract][Full Text] [Related]
8. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine. Cass WA; Smith MP; Peters LE Ann N Y Acad Sci; 2006 Aug; 1074():261-71. PubMed ID: 17105922 [TBL] [Abstract][Full Text] [Related]
9. Lobeline inhibits the neurochemical and behavioral effects of amphetamine. Miller DK; Crooks PA; Teng L; Witkin JM; Munzar P; Goldberg SR; Acri JB; Dwoskin LP J Pharmacol Exp Ther; 2001 Mar; 296(3):1023-34. PubMed ID: 11181937 [TBL] [Abstract][Full Text] [Related]
10. Psychostimulants and vesicle trafficking: a novel mechanism and therapeutic implications. Hanson GR; Sandoval V; Riddle E; Fleckenstein AE Ann N Y Acad Sci; 2004 Oct; 1025():146-50. PubMed ID: 15542712 [TBL] [Abstract][Full Text] [Related]
11. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. Bowyer JF; Davies DL; Schmued L; Broening HW; Newport GD; Slikker W; Holson RR J Pharmacol Exp Ther; 1994 Mar; 268(3):1571-80. PubMed ID: 8138969 [TBL] [Abstract][Full Text] [Related]
12. Alterations in vesicular dopamine uptake contribute to tolerance to the neurotoxic effects of methamphetamine. Johnson-Davis KL; Truong JG; Fleckenstein AE; Wilkins DG J Pharmacol Exp Ther; 2004 May; 309(2):578-86. PubMed ID: 14747615 [TBL] [Abstract][Full Text] [Related]
13. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia. Metzger RR; Haughey HM; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE J Pharmacol Exp Ther; 2000 Dec; 295(3):1077-85. PubMed ID: 11082443 [TBL] [Abstract][Full Text] [Related]
14. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions. Broening HW; Morford LL; Vorhees CV Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503 [TBL] [Abstract][Full Text] [Related]
15. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine. Bjorklund NL; Sorg BA; Schenk JO Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643 [TBL] [Abstract][Full Text] [Related]
16. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. Albers DS; Sonsalla PK J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070 [TBL] [Abstract][Full Text] [Related]
17. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. Brown JM; Hanson GR; Fleckenstein AE J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904 [TBL] [Abstract][Full Text] [Related]
18. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. Itzhak Y; Gandia C; Huang PL; Ali SF J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865 [TBL] [Abstract][Full Text] [Related]
19. Age-dependent effects of methamphetamine on VMAT-2. Rau KS; Truong JG; Wilkins DG; Fleckenstein AE; Hanson GR Ann N Y Acad Sci; 2006 Aug; 1074():154-9. PubMed ID: 17105913 [TBL] [Abstract][Full Text] [Related]
20. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. Bowyer JF; Tank AW; Newport GD; Slikker W; Ali SF; Holson RR J Pharmacol Exp Ther; 1992 Feb; 260(2):817-24. PubMed ID: 1346646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]